share_log

Truist Securities Reinstates Hold on Instil Bio, Maintains $6 Price Target

Benzinga ·  Apr 5, 2023 08:54

Truist Securities analyst Asthika Goonewardene reinstates Instil Bio (NASDAQ:TIL) with a Hold and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment